Hologic, Inc.
http://www.hologic.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Hologic, Inc.
News We’re Watching: Panel Backs Guardant Shield, EU Adopts AI Act, Magellan Settles Lead Test Claims
This week, an FDA advisory panel recommended approval of the Guardant Shield blood test for colon and rectal cancers; the EU Council signed off on the world’s first AI law; and the FDA challenged innovators to develop AI/ML technologies to detect gait freezing in individuals with Parkinson’s disease
‘Indomitable Spirit’ Spurs Incontinence Treatment Firm Axena
Axena Health recently secured a HCPCS code for its female incontinence device Leva. For CEO Eileen Maus, this is just the latest in a string of successes across the women’s health, or femtech, sector.
Pfizer’s Super Bowl Commercial Departs From Drug Ad Format
In its first corporate Super Bowl ad, Pfizer celebrates history of scientific discoveries while promoting its cancer research. Astellas airs pre-game commercial for menopausal drug Veozah.
News We’re Watching: CDRH Announces Cybersecurity Collaboration, Electrostim Faces Lawsuit, FDA Recalls And Approvals
This week, the FDA extended a comment period on digital health tools to detect diabetes; Theradaptive launched a trial of its spinal fusion device; and devices from Hologic and GE Healthcare won FDA clearance.
Company Information
- Industry
- Contract Research Organization-CRO
- In Vitro Diagnostics
- Laboratory Testing Services
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Ultrasound
- X-ray
-
Diagnostic Imaging Equipment & Supplies
- Other Names / Subsidiaries
-
- Acessa Health Inc.
- Biotheranostics, Inc.
- Bolder Surgical, Cytyc Corporation
- Faxitron Bioptics, LLC
- Focal Therapeutics, Inc.
- Gen-Probe Inc.
- Interlace Medical Inc.
- Novacept
- Palomar Medical Techologies
- Prodesse
- SuperSonic Imagine
- Third Wave Technologies
- SOMATEX Medical Technologies GmbH
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice